Bio-Rad Laboratories, Inc. - Laporan Laba Rugi (TTM)

Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905721082

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Bio-Rad Laboratories, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 2,380 2,546 2,701 2,880 2,980 2,923 2,896 2,871 2,805 2,802 2,779 2,769 2,720 2,671 2,605 2,563 2,580 2,566 2,541 2,554
Change (%) 6.95 6.09 6.63 3.46 -1.92 -0.91 -0.86 -2.31 -0.09 -0.83 -0.36 -1.76 -1.81 -2.47 -1.64 0.69 -0.53 -0.99 0.52
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,060 1,108 1,180 1,250 1,280 1,259 1,231 1,212 1,211 1,235 1,251 1,273 1,262 1,244 1,214 1,178 1,176 1,188 1,178 1,202
Change (%) 4.50 6.50 5.97 2.37 -1.59 -2.28 -1.48 -0.11 1.97 1.29 1.80 -0.93 -1.37 -2.41 -2.96 -0.22 1.01 -0.81 1.99
% of Revenue 44.53 43.52 43.68 43.41 42.95 43.09 42.50 42.23 43.18 44.07 45.01 45.99 46.38 46.58 46.61 45.98 45.57 46.27 46.36 47.04
Gross Operating Profit 1,320 1,438 1,521 1,630 1,700 1,663 1,665 1,659 1,594 1,567 1,528 1,496 1,459 1,427 1,391 1,384 1,404 1,379 1,363 1,353
Change (%) 8.91 5.79 7.14 4.30 -2.16 0.12 -0.39 -3.91 -1.65 -2.49 -2.13 -2.47 -2.19 -2.52 -0.48 1.46 -1.82 -1.15 -0.76
% of Revenue 55.47 56.48 56.32 56.59 57.05 56.91 57.50 57.77 56.82 55.93 54.99 54.01 53.62 53.42 53.39 54.02 54.43 53.73 53.64 52.96
SG&A 784 799 832 857 875 851 821 814 808 828 854 853 843 842 827 815 815 814 797 806
Change (%) 1.94 4.20 2.99 2.09 -2.75 -3.52 -0.81 -0.73 2.39 3.13 -0.03 -1.20 -0.18 -1.79 -1.37 -0.08 -0.08 -2.09 1.14
% of Revenue 32.92 31.38 30.82 29.77 29.37 29.12 28.35 28.37 28.83 29.54 30.72 30.82 31.00 31.51 31.73 31.82 31.57 31.72 31.36 31.56
R&D 212 218 251 263 268 247 233 234 236 257 272 273 250 247 237 231 279 296 292 293
Change (%) 2.81 15.36 4.54 1.88 -7.55 -5.81 0.41 0.99 8.74 5.96 0.26 -8.53 -0.89 -4.35 -2.30 20.53 6.18 -1.35 0.41
% of Revenue 8.90 8.55 9.30 9.12 8.98 8.46 8.04 8.15 8.42 9.17 9.79 9.86 9.18 9.26 9.08 9.02 10.80 11.53 11.49 11.48
OpEx 2,055 2,124 2,263 2,370 2,422 2,358 2,285 2,261 2,256 2,320 2,377 2,400 2,354 2,333 2,278 2,225 2,269 2,298 2,267 2,301
Change (%) 3.35 6.54 4.71 2.21 -2.67 -3.10 -1.05 -0.22 2.83 2.46 0.97 -1.89 -0.89 -2.39 -2.31 1.99 1.25 -1.33 1.49
% of Revenue 86.35 83.45 83.80 82.29 81.30 80.68 78.90 78.75 80.43 82.78 85.52 86.66 86.55 87.35 87.43 86.82 87.94 89.52 89.21 90.08
Operating Income 325 421 438 510 557 565 611 610 549 483 402 369 366 338 328 338 311 269 274 254
Change (%) 29.71 3.85 16.53 9.28 1.35 8.21 -0.15 -10.04 -12.08 -16.63 -8.20 -0.92 -7.69 -3.02 3.08 -7.87 -13.53 1.93 -7.55
% of Revenue 13.65 16.55 16.20 17.71 18.70 19.32 21.10 21.25 19.57 17.22 14.48 13.34 13.45 12.65 12.57 13.18 12.06 10.48 10.79 9.92
Interest Expense -23 -22 -17 -11 -6 -2 -5 -16 -27 -38 -46 -48 -49 -49 -49 -49 -49 -49 -49 -49
Change (%) -5.86 -24.21 -32.45 -47.37 -73.67 235.33 199.13 72.23 42.19 21.79 3.50 1.53 1.31 -0.07 -0.29 -0.46 -0.20 -0.61 0.82
% of Revenue -0.98 -0.86 -0.61 -0.39 -0.20 -0.05 -0.18 -0.54 -0.96 -1.36 -1.67 -1.73 -1.79 -1.85 -1.89 -1.92 -1.90 -1.91 -1.91 -1.92
Net Income 3,521 3,814 4,098 4,045 6,659 4,254 -91 -1,930 -6,021 -3,628 -191 -428 -159 -637 -322 -1,326 -779 -1,844 -2,164 319
Change (%) 8.34 7.43 -1.28 64.60 -36.11 -102.13 2,032.21 211.99 -39.75 -94.73 124.01 -62.81 300.07 -49.42 311.22 -41.26 136.83 17.35 -114.75
% of Revenue 147.91 149.83 151.73 140.48 223.47 145.57 -3.13 -67.22 -214.66 -129.45 -6.88 -15.47 -5.86 -23.86 -12.37 -51.73 -30.18 -71.86 -85.16 12.50

Source: Capital IQ

Other Listings
DE:BUW € 230.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista